| Abstract: | The effects of N-methyl-
-aspartate (NMDA), kainate and (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA), ionotropic glutamate agonists, on gastric acid secretion were investigated in the continuously perfused stomach of anesthetized rats. The lateral ventricular (LV) injection of kainate (0.01–1 μg) or NMDA (0.3–3 μg) dose-dependently stimulated gastric acid secretion. AMPA (3–10 μg) also stimulated gastric acid secretion but the effect was very weak. Repeated injections of kainate (0.1 μg) or NMDA (1 μg), at least twice, stimulated gastric acid secretion to a similar degree. The effect of kainate (0.1 μg) was blocked by the kainate receptor antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione disodium (3 μg, LV) and
-γ-glutamylaminomethanesulfonic acid (30 μg, LV), but not by NMDA receptor antagonists. The effect of NMDA (10 μg) was blocked by (±)-3-(2-carboxypiperazin-4-yl)-1-propylphosphonic acid (10 μg, LV), a competitive NMDA receptor antagonist, and (+)-5-methyl-10,11-dihydro-5H-dibenzocyclo-hepten-5,10-imine hydrogen maleate (10 μg, LV), a non-competitive NMDA receptor antagonist, but not by kainate receptor antagonists. Moreover, the gastric acid secretion stimulated by kainate and NMDA were completely blocked by systemic atropine injection (1 mg/kg, i.v.) and vagotomy. These findings suggest that kainate and NMDA receptor mechanisms are independently involved in the central nervous system to control gastric acid secretion through vagus cholinergic activation. |
